Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox

This publication has 48 references indexed in Scilit:

• Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses
  Antimicrobial Agents and Chemotherapy, 2002
• Blocking Smallpox: A Second Defense
  Science, 2001
• Phase II Double‐Blind, Placebo‐Controlled Study of the Safety and Efficacy of Cidofovir Topical Gel for the Treatment of Patients with Human Papillomavirus Infection
  Clinical Infectious Diseases, 2001
• Treatment of Acyclovir-Resistant, Foscarnet-Unresponsive HSV Infection With Topical Cidofovir in a Child With AIDS
  Archives of Dermatology, 1998
• A Randomized, Double‐Blind, Placebo‐Controlled Trial of Cidofovir Gel for the Treatment of Acyclovir‐Unresponsive Mucocutaneous Herpes Simplex Virus Infection in Patients with AIDS
  The Journal of Infectious Diseases, 1997
• Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus
  Antiviral Research, 1995
• Successful Treatment of Progressive Mucocutaneous Infection Due to Acyclovirand Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine (HPMPC)
  Clinical Infectious Diseases, 1994
• Human Papillomavirus DNA in Locally Recurrent Cervical Cancer
  Gynecologic Oncology, 1994
• Efficacy of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice
  Journal of Medical Virology, 1993
• HPV DNA in Intraepithelial Neoplasia and Carcinoma of the Vulva and Penis
  Diagnostic Molecular Pathology, 1992